These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 33704001

  • 1. Effects of TNF inhibitors and an IL12/23 inhibitor on changes in body weight and adipokine levels in psoriasis patients: a 48-week comparative study.
    Onsun N, Akaslan TÇ, Sallahoglu K, Gülcan AS, Bulut H, Yabacı A.
    J Dermatolog Treat; 2022 May; 33(3):1727-1732. PubMed ID: 33704001
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings.
    Olejniczak-Staruch I, Narbutt J, Ceryn J, Skibińska M, Bednarski I, Woźniacka A, Sieniawska J, Kraska-Gacka M, Ciążyńska M, Śmigielski J, Noweta M, Waszczykowski M, Owczarek W, Reich A, Lesiak A.
    Sci Rep; 2021 Apr 29; 11(1):9289. PubMed ID: 33927259
    [Abstract] [Full Text] [Related]

  • 6. Comparative effectiveness of adalimumab versus ustekinumab in the treatment of severe chronic plaque psoriasis: The results based on data from the program "treatment of moderate and severe forms of plaque psoriasis (B.47)" of the National Health Fund in Poland.
    Owczarek W, Nowakowska A, Walecka I, Ciechanowicz P, Reich A, Lesiak A, Borkowska E, Śliwczyński A, Narbutt J.
    Dermatol Ther; 2022 Jun 29; 35(6):e15481. PubMed ID: 35363386
    [Abstract] [Full Text] [Related]

  • 7. Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study.
    Talamonti M, Galluzzo M, Bernardini N, Caldarola G, Persechino S, Cantoresi F, Egan CG, Potenza C, Peris K, Bianchi L.
    J Eur Acad Dermatol Venereol; 2018 Oct 29; 32(10):1737-1744. PubMed ID: 29776016
    [Abstract] [Full Text] [Related]

  • 8. Biologics for Psoriasis.
    Wride AM, Chen GF, Spaulding SL, Tkachenko E, Cohen JM.
    Dermatol Clin; 2024 Jul 29; 42(3):339-355. PubMed ID: 38796266
    [Abstract] [Full Text] [Related]

  • 9. Efficacy comparison of ustekinumab between anti-tumor necrosis factor-α drug-naïve and anti-tumor necrosis factor-α drug-resistant Japanese psoriasis cases.
    Takahashi N, Noda S, Taniguchi T, Adachi M.
    Int J Dermatol; 2015 Oct 29; 54(10):1194-8. PubMed ID: 26016819
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR.
    Mason KJ, Barker JNWN, Smith CH, Hampton PJ, Lunt M, McElhone K, Warren RB, Yiu ZZN, Griffiths CEM, Burden AD, BADBIR Study Group.
    JAMA Dermatol; 2018 May 01; 154(5):581-588. PubMed ID: 29590279
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis.
    Xue W, Saharia P, Gray E, Khoudigian-Sinani S, Gaudet V, Barbeau M, Papp K.
    J Cutan Med Surg; 2020 May 01; 24(6):561-572. PubMed ID: 32588642
    [Abstract] [Full Text] [Related]

  • 13. Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort.
    Van Muijen ME, Thomas SE, Groenewoud HMM, Otero ME, Ossenkoppele PM, Njoo MD, Dodemont SRP, Kop EN, Berends MAM, Koetsier MIA, Mommers JM, Körver JEM, Tupker RA, De Bruin-Weller MS, Weppner-Parren LJMT, Peters B, Kleinpenning MM, Kuijpers ALA, Arnold WP, Van Lümig PPM, Van den Reek JMPA, De Jong EMGJ.
    Acta Derm Venereol; 2022 May 16; 102():adv00712. PubMed ID: 35356990
    [Abstract] [Full Text] [Related]

  • 14. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis.
    Griffiths CE, Strober BE, van de Kerkhof P, Ho V, Fidelus-Gort R, Yeilding N, Guzzo C, Xia Y, Zhou B, Li S, Dooley LT, Goldstein NH, Menter A, ACCEPT Study Group.
    N Engl J Med; 2010 Jan 14; 362(2):118-28. PubMed ID: 20071701
    [Abstract] [Full Text] [Related]

  • 15. Serum C-reactive protein levels in Japanese patients with psoriasis and psoriatic arthritis: Long-term differential effects of biologics.
    Asahina A, Umezawa Y, Yanaba K, Nakagawa H.
    J Dermatol; 2016 Jul 14; 43(7):779-84. PubMed ID: 26704718
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial.
    Ritchlin C, Rahman P, Kavanaugh A, McInnes IB, Puig L, Li S, Wang Y, Shen YK, Doyle MK, Mendelsohn AM, Gottlieb AB, PSUMMIT 2 Study Group.
    Ann Rheum Dis; 2014 Jun 14; 73(6):990-9. PubMed ID: 24482301
    [Abstract] [Full Text] [Related]

  • 18. Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort.
    Zweegers J, Roosenboom B, van de Kerkhof PC, van den Reek JM, Otero ME, Atalay S, Kuijpers AL, Koetsier MI, Arnold WP, Berends MA, Weppner-Parren L, Bijen M, Njoo MD, Mommers JM, van Lümig PP, Driessen RJ, Kievit W, de Jong EM.
    Br J Dermatol; 2017 Mar 14; 176(3):786-793. PubMed ID: 27454758
    [Abstract] [Full Text] [Related]

  • 19. Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis.
    Feldman SR, Zhao Y, Navaratnam P, Friedman HS, Lu J, Tran MH.
    J Manag Care Spec Pharm; 2015 Mar 14; 21(3):201-9. PubMed ID: 25726029
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.